Cytosorbents (CTSO) Assets (QoQ) (2011 - 2026)
Cytosorbents (CTSO) Assets (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | Cytosorbents | 23.46 Mn | 18.66 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.19% |
| Dec 31, 2025 | -3.43% |
| Sep 30, 2025 | -4.67% |
| Jun 30, 2025 | -5.50% |
| Mar 31, 2025 | 7.20% |
| Dec 31, 2024 | -0.90% |
| Sep 30, 2024 | -10.52% |
| Jun 30, 2024 | 13.50% |
| Mar 31, 2024 | -11.11% |
| Dec 31, 2023 | 11.31% |
| Sep 30, 2023 | -9.29% |
| Jun 30, 2023 | -8.73% |
| Mar 31, 2023 | -9.12% |
| Dec 31, 2022 | 1.54% |
| Sep 30, 2022 | -12.55% |
| Jun 30, 2022 | -14.49% |
| Mar 31, 2022 | -6.98% |
| Dec 31, 2021 | -5.84% |
| Sep 30, 2021 | -3.18% |
| Jun 30, 2021 | 12.25% |